Hosted on MSN11mon
Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancerScientists have found that certain molecules called chemokines—specifically, CXCL9 and CXCL10—play a crucial role in attracting immune cells, particularly activated T cells, to the tumor site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback